Antibiotics, Dosing, and CFTR

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/93/80/a3/9380a3e6-8135-ddbc-2128-1011bf954bd7/mza_3707003826622290779.jpeg/600x600bb.jpg

eCysticFibrosis Review

72 episodes

8 months ago

Expert insight and analysis providing information directly relevant to cystic fibrosis care, through topic-focused newsletters summarizing the peer-reviewed literature and accompanying podcasts to illustrate how to apply that information in the clinic.

Hosted on Acast. See acast.com/privacy for more information.

All content for eCysticFibrosis Review is the property of eCysticFibrosis Review and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Hosted on Acast. See acast.com/privacy for more information.

Medicine

Education,

Health & Fitness

https://assets.pippa.io/shows/5fa6e32f007fe14c6dd46501/1606253804927-69bc6fa41f10b681f9e107817aaf4a51.jpeg

Antibiotics, Dosing, and CFTR

eCysticFibrosis Review

17 minutes 46 seconds

5 years ago

Antibiotics, Dosing, and CFTR

Airway infections are a hallmark of cystic fibrosis, making antibiotic therapies a mainstay of CF treatment. While the fight against ABX resistance is ongoing, newer data are showing that commonly used dosing regimens may have to be altered to account for the particular pharmacodynamics in people with CF. How should ABX dosing be altered, and what additional effect might CFTR modulation have on dosing decisions?

That’s the topic Dr. Andrea Hahn, Assistant Professor of Pediatrics and an Infectious Disease Specialist at Children’s National Medical Center and George Washington University School of Medicine and Health Sciences, addresses in this eCysticFibrosis Review podcast.

Take our post-test to claim CME credits.

To read a companion newsletter click here.

Hosted on Acast. See acast.com/privacy for more information.